Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
Aziz
T M
TM
Department of Transplantation Surgery, Wyhenshawe Hospital, Manchester, United Kingdom.
Sheldon
S
S
el-Gamel
A
A
Krysiak
P
P
Campbell
C
C
Rahman
A
A
Dyer
P
P
Yonan
N
N
Deiraniya
A
A
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003324:Coronary Artery Disease / Q000453:epidemiology; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000473:pathology; D006334:Heart Function Tests; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone